Next Article in Journal
Utilization of a Machine Learning Algorithm for the Application of Ancillary Features to LI-RADS Categories LR3 and LR4 on Gadoxetate Disodium-Enhanced MRI
Previous Article in Journal
Current Trends in Mucosal Melanomas: An Overview
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 15
Issue 5
10.3390/cancers15051359
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Cancers 2020, 12(12), 3745.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745

by
Mirjam Esther van de Velde
1,*,
Gertjan J. L. Kaspers
1,2,
Floor C. H. Abbink
3,
Jos W. R. Twisk
4,
Inge M. van der Sluis
2,5,
Cor van den Bos
2,3,
Marry M. van den Heuvel-Eibrink
2,
Heidi Segers
6,
Christophe Chantrain
7,
Jutte van der Werff ten Bosch
8,
Leen Willems
9 and
Marleen H. van den Berg
1
1
Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1081 HV Amsterdam, The Netherlands
2
Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands
3
Emma Children’s Hospital, Amsterdam UMC, Amsterdam Medical Center, Pediatric Oncology, 1105 AZ Amsterdam, The Netherlands
4
Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands
5
Department of Pediatric Oncology, Erasmus Medical Center Rotterdam/Sophia Children’s Hospital, 3000 CB Rotterdam, The Netherlands
6
Department of Pediatric Hemato-Oncology, University Hospitals Leuven, 3000 Leuven, Belgium
7
Department of Pediatrics, Clinique du MontLégia, CHC, 4000 Liège, Belgium
8
Department of Pediatric Onco-Hematology, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium
9
Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, 9000 Ghent, Belgium
*
Author to whom correspondence should be addressed.
Cancers 2023, 15(5), 1359; https://doi.org/10.3390/cancers15051359
Submission received: 21 September 2022 / Accepted: 29 November 2022 / Published: 21 February 2023
Versions Notes

Error in Table

In the original publication, there was a mistake in Table 1 as published [1]. The number of patients with death was swapped between the one-hour administration group and the push administration group. The corrected Table 1 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Van de Velde, M.E.; Kaspers, G.J.L.; Abbink, F.C.H.; Twisk, J.W.R.; van der Sluis, I.M.; van den Bos, C.; van den Heuvel-Eibrink, M.M.; Segers, H.; Chantrain, C.; van der Werff Ten Bosch, J.; et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745. [Google Scholar] [CrossRef] [PubMed]
Table
Table 1. Demographic and clinical characteristics of the participants at baseline.
Table 1. Demographic and clinical characteristics of the participants at baseline.
One-Hour Administration Group (n = 45)Push Administration Group (n = 45)
Sex
Male26 (58)24 (53)
Female19 (42)21 (47)
Age, years (mean(SD))9.06 (5.11)9.29 (5.25)
Age ≥ 5 years and included for ped-mTNS assessment32 (71)34 (76)
Disease
Acute lymphoblastic leukemia29 (64)29 (64)
Hodgkin lymphoma7 (16)11 (24)
Nephroblastoma6 (13)2 (4)
Medulloblastoma1 (2)1 (2)
Rhabdomyosarcoma2 (4)0 (0)
Low-grade glioma0 (0)2 (4)
Ancestry a
Europe36 (80)37 (82)
Eastern Asia1 (2)0 (0)
Latin-America (including Caribbean)1 (2)2 (4)
Middle-East (including Northern Africa)3 (7)3 (7)
Sub-Saharan Africa1 (2)0 (0)
Combination2 (4)3 (7)
Missing1 (2)0 (0)
No. (%) of patients needing VCR dose reductions or omissions1 (3)0 (0)
No. (%) of patients using analgesics for neuropathic pain9 (20)11 (24)
Relapse (No. (%))2 (4)1 (2)
Death (No. (%))3 (7)1 (2)
Values represent the number (%) of participants, unless indicated otherwise. SD: standard deviation; ped-mTNS: pediatric modified Total Neuropathy Score; VCR: vincristine, a: Ancestry was self- or parent-reported; participants could only be included in one category.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

van de Velde, M.E.; Kaspers, G.J.L.; Abbink, F.C.H.; Twisk, J.W.R.; van der Sluis, I.M.; van den Bos, C.; van den Heuvel-Eibrink, M.M.; Segers, H.; Chantrain, C.; van der Werff ten Bosch, J.; et al. Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745. Cancers 2023, 15, 1359. https://doi.org/10.3390/cancers15051359

AMA Style

van de Velde ME, Kaspers GJL, Abbink FCH, Twisk JWR, van der Sluis IM, van den Bos C, van den Heuvel-Eibrink MM, Segers H, Chantrain C, van der Werff ten Bosch J, et al. Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745. Cancers. 2023; 15(5):1359. https://doi.org/10.3390/cancers15051359

Chicago/Turabian Style

van de Velde, Mirjam Esther, Gertjan J. L. Kaspers, Floor C. H. Abbink, Jos W. R. Twisk, Inge M. van der Sluis, Cor van den Bos, Marry M. van den Heuvel-Eibrink, Heidi Segers, Christophe Chantrain, Jutte van der Werff ten Bosch, and et al. 2023. "Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745" Cancers 15, no. 5: 1359. https://doi.org/10.3390/cancers15051359

APA Style

van de Velde, M. E., Kaspers, G. J. L., Abbink, F. C. H., Twisk, J. W. R., van der Sluis, I. M., van den Bos, C., van den Heuvel-Eibrink, M. M., Segers, H., Chantrain, C., van der Werff ten Bosch, J., Willems, L., & van den Berg, M. H. (2023). Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial). Cancers 2020, 12, 3745. Cancers, 15(5), 1359. https://doi.org/10.3390/cancers15051359

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop